PF-514273
PF-514273 is a drug developed by Pfizer, which acts as an extremely selective antagonist for the CB 1 receptor, with approximately 10,000x selectivity over the closely related CB 2 receptor.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
PF-514273 is a drug developed by Pfizer, which acts as an extremely selective antagonist for the CB 1 receptor, with approximately 10,000x selectivity over the closely related CB 2 receptor. This very high selectivity makes it useful for scientific research into these receptors, as many commonly used cannabinoid receptor antagonists also block the CB 2 receptor to some extent.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330450348 under CC BY-SA 4.0; modifications have been made.